Novo Nordisk A/S
CSE:NOVO B

Watchlist Manager
Novo Nordisk A/S Logo
Novo Nordisk A/S
CSE:NOVO B
Watchlist
Price: 304.3 DKK -1.25% Market Closed
Market Cap: 1.4T DKK

EV/EBIT
Enterprise Value to EBIT

10.6
Current
25.6
Median
16.6
Industry
Lower than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
10.6
=
Enterprise Value
1.4T DKK
/
EBIT
132.7B DKK
All Countries
Close
Market Cap EV/EBIT
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 10.6
US
Eli Lilly and Co
NYSE:LLY
999.6B USD 39.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 17 702.3
US
Johnson & Johnson
NYSE:JNJ
501.2B USD 21.2
CH
Roche Holding AG
SIX:ROG
254.4B CHF 13.5
UK
AstraZeneca PLC
LSE:AZN
210.1B GBP 158.5
CH
Novartis AG
SIX:NOVN
206.7B CHF 14.8
US
Merck & Co Inc
NYSE:MRK
250.5B USD 11.1
IE
Endo International PLC
LSE:0Y5F
209B USD 830.4
US
Pfizer Inc
NYSE:PFE
142.4B USD 10.1
FR
Sanofi SA
PAR:SAN
99.9B EUR 6.6
EBIT Growth EV/EBIT to Growth
DK
Novo Nordisk A/S
CSE:NOVO B
Average EV/EBIT: 1 710.7
10.6
1%
10.6
US
Eli Lilly and Co
NYSE:LLY
39.1
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.2
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.5
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
158.5
23%
6.9
CH
Novartis AG
SIX:NOVN
14.8
12%
1.2
US
Merck & Co Inc
NYSE:MRK
11.1
8%
1.4
IE
E
Endo International PLC
LSE:0Y5F
830.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.1
8%
1.3
FR
Sanofi SA
PAR:SAN
6.6
15%
0.4

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
10.6
2-Years Forward
EV/EBIT
10.4
3-Years Forward
EV/EBIT
9.7